The Lancet Planetary Health, Volume 6, February 2022,
Background: Over 3 million people die every year from diseases caused by exposure to outdoor PM2·5 air pollution, and more than a quarter of these premature deaths occur in China. In addition to clean-air policies that target pollution emissions, climate policies aimed at reducing fossil-fuel CO2 emissions (eg, to avoid 1·5°C of warming) might also greatly improve air quality and public health. However, no comprehensive accounting of public health outcomes has been done under different energy pathways and local clean-air management decisions in China. We aimed to develop an integrated method for quantifying the health co-benefits from different climate, energy, and clean-air policy scenarios and to assess the relationship between climate and clean-air policies and future health burdens in China, where an ageing population will further exacerbate the effects of air pollution. Methods: For this modelling study, we used a China-focused integrated assessment model and a dynamic emission projection model to project future Chinese air quality in scenarios spanning a range of global climate targets (1·5°C, 2°C, national determined contributions [NDC], unambitious, baseline, and 4·5°C) and national clean-air actions (termed 2015-pollution, current-pollution, and ambitious-pollution). We then evaluated the health effects of PM2·5 air pollution in the scenario matrix using the air quality model and the latest epidemiological concentration–response functions from the 2019 Global Burden of Diseases, Injuries, and Risk Factors Study. Findings: We found that, without ambitious climate mitigation (eg, under current NDC pledge), Chinese deaths related to PM2·5 air pollution might not always decrease—and might often grow—by 2050 compared with the base year of 2015, regardless of clean-air policies and air quality improvements. For example, in the scenario that tracks China's current NDC pledge and uses the best available pollution control technologies (the ambitious-pollution and NDC goals scenario), PM2·5-related deaths in China would decrease slightly by 2030 to 1·23 million per year (95% CI 0·95–1·51) from 1·25 million (1·04–1·46) in 2015, but would not decrease further by 2050 (1·21 million, 0·86–1·60) despite substantial and continuous improvements in population-weighted air quality (from 27·2 μg/m3 in 2030 to 16·0 μg/m3 in 2050). The contrary trends of improving air quality and increasing PM2·5-related deaths in many of our scenarios revealed the extent to which extra efforts are needed to compensate for the increasing age of China's population in the future. With the scenarios that included ambitious clean-air policies and met international climate goals to avoid 1·5°C and 2°C of warming (the ambitious-pollution-2°C goals scenario and the ambitious-pollution-1·5°C goals scenario), we observed substantial decreases in China's PM2·5-related deaths of 0·32–0·55 million deaths compared with NDC goals in 2050, and age-standardised death rates decreased by 10·2–14·2 deaths per 100 000 population per year. Interpretation: Our results show that ambitious climate policies (ie, limiting global average temperature rise to well below 2°C) and low-carbon energy transitions coupled with stringent clean-air policies are necessary to substantially reduce the human health effects from air pollution in China, regardless of socioeconomic assumptions. Our findings could help policy makers understand the crucial links between climate policy and public health. Funding: The National Natural Science Foundation of China.
Adverse Event; Air Pollutant; Air Pollutants; Air Pollution; Air Quality; Article; Cerebrovascular Accident; China; Chronic Obstructive Lung Disease; Climate Change; Disease Burden; Economic Development; Environmental Economics; Environmental Policy; Environmental Temperature; Epidemiology; Global Climate; Goals; Health Hazard; Human; Humans; Ischemic Heart Disease; Lung Cancer; Mortality Rate; Motivation; Particulate Matter; Particulate Matter 2.5; Policy; Pollution Control; Predictive Model; Prevention And Control; Public Health; Respiratory Tract Infection; Socioeconomics; Asia